Skip to main content
. Author manuscript; available in PMC: 2012 Feb 15.
Published in final edited form as: Cancer Res. 2011 Jul 1;71(16):5558–5568. doi: 10.1158/0008-5472.CAN-10-4543

Figure 1. GPR56 inhibits angiogenesis in melanomas.

Figure 1

A. Expression of GPR56 resulted in reduction in angiogenesis. Tumor sections from melanoma cells expressing wild-type GPR56 or vector control were stained with anti-GPRC antibody (red) and anti-PECAM antibody (green).

B. Quantification of blood vessel density in GPR56-expressing tumors and vector control.

C. Quantifications of blood vessel density in areas of the same GPR56-expressing tumors.